[论文解读] Grothendieck homomorphisms in algebraically closed valued fields III: Fourier transform

Yimu Yin|arXiv (Cornell University)|Mar 6, 2009

Advanced Algebra and Geometry参考文献 5被引用 1

一句话总结

本研究证明，葛根素通过抑制NF-κB信号通路，抑制钛颗粒诱导的炎症性骨溶解。它在体外阻断破骨细胞的分化和活化，并在体内减少骨吸收和促炎细胞因子，提示葛根素可能是治疗骨溶解相关疾病的一种有前景的治疗剂。

ABSTRACT

Osteolysis around the prosthesis and subsequent aseptic loosening are the main causes of prosthesis failure. Inflammation due to wear particles and osteoclast activation are the key factors in osteolysis and are also potential targets for the treatment of osteolysis. However, it is not clear whether puerarin can inhibit chronic inflammation and alleviate osteolysis. In this study, we investigated the effect of puerarin on Ti particle-induced inflammatory osteolysis in vivo in rat femoral models and in vitro in receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast activation models. Our in vivo results showed that puerarin significantly inhibited Ti particle-induced osteolysis and the expression of matrix metallopeptidase 9 (MMP-9), nuclear factor of activated T cells 1 (NFATc1), tumour necrosis factor (TNF)-α and interleukin (IL)-6. In vitro, puerarin prevented RANKL-induced osteoclast differentiation, bone resorption and F-actin ring formation in a concentration-dependent manner. Furthermore, puerarin decreased the phosphorylation of p65 and prevented p65 moving from the cytoplasm to the nucleus. Puerarin also reduced the expression of osteoclast-specific factors and inhibited the inflammatory response. In conclusion, our study proves that puerarin can block the NF-κB signalling pathway to inhibit osteoclast activation and inflammatory processes, which provides a new direction for the treatment of osteolysis-related diseases.

研究动机与目标

• 探讨葛根素是否能抑制钛磨损颗粒诱导的慢性炎症和骨溶解。
• 评估葛根素对RANKL诱导的破骨细胞生成模型中破骨细胞分化和骨吸收的影响。
• 确定葛根素在破骨细胞中调节NF-κB信号通路的作用。
• 评估葛根素在大鼠股骨模型中减少骨溶解和炎症标志物的体内疗效。

提出的方法

• 使用大鼠股骨模型，通过植入钛颗粒诱导骨溶解，进行体内评估。
• 使用骨髓来源的巨噬细胞在RANKL刺激下进行体外破骨细胞分化。
• 以不同浓度的葛根素处理，评估其对破骨细胞形成和功能的剂量依赖性影响。
• 通过免疫荧光和Western印迹分析检测NF-κB的p65磷酸化及其核转位。
• 通过定量RT-PCR和ELISA检测MMP-9、NFATc1、TNF-α和IL-6的表达水平。
• 通过组织学和micro-CT分析评估体内骨破坏和骨溶解性病灶的形成。

实验结果

研究问题

• RQ1 葛根素是否能减轻大鼠股骨模型中钛颗粒诱导的骨溶解？
• RQ2 葛根素是否能抑制体外RANKL诱导的破骨细胞分化和骨吸收？
• RQ3 葛根素是否能抑制前体破骨细胞中NF-κB通路的活化？
• RQ4 葛根素对破骨细胞特异性标志物和促炎细胞因子的表达有何影响？

主要发现

• 在钛颗粒植入后，葛根素显著减少了大鼠股骨模型中的骨溶解性病灶体积和骨量丢失。
• 体外实验中，葛根素呈剂量依赖性地抑制破骨细胞形成、F-肌动蛋白环形成和骨吸收活性。
• 葛根素抑制了p65的磷酸化并阻止其核转位，表明其抑制了NF-κB的活化。
• 葛根素在体内和体外模型中均下调了NFATc1、MMP-9、TNF-α和IL-6的表达。
• 葛根素的抗破骨细胞生成和抗炎作用通过抑制NF-κB信号通路介导。
• 葛根素治疗显著降低了炎症细胞因子水平和破骨细胞特异性转录因子的表达。